Tribenoside

Tribenoside
Clinical data
Other names	(3R,4R,5R)-4-(Benzyloxy)-5--2-ethoxyoxolan-3-ol
AHFS/Drugs.com	International Drug Names
ATC code	C05AX05 (WHO) C05CX01 (WHO);
Identifiers
	IUPAC name Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside (TBGF);
CAS Number	10310-32-4 ;
PubChem CID	196122;
ChemSpider	169970 ;
UNII	Z7N0Y673NU;
ChEMBL	ChEMBL1446743 ;
CompTox Dashboard (EPA)	DTXSID7023697 ;
ECHA InfoCard	100.030.612
Chemical and physical data
Formula	C29H34O6
Molar mass	478.585 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCOC1(((O1)(COCc2ccccc2)OCc3ccccc3)OCc4ccccc4)O;
	InChI InChI=1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25-,26-,27-,28-,29?/m1/s1 ; Key:ULLNJSBQMBKOJH-VIVFLBMVSA-N ;
	(what is this?) (verify)

Tribenoside (Glyvenol) is a vasoprotective drug used to treat hemorrhoids.^[1] It has mild anti-inflammatory, analgesic, and wound healing properties.^[2] Tribenoside stimulates laminin α5 production and laminin-332 deposition to help repair the basement membrane during the wound healing process.^[3] It is a mixture of the α- and β-anomers.^{[citation needed]}

Tribenoside has been shown to induce drug hypersensitivity syndrome in association with CMV reactivation.^[4]

References

^ Lorenc Z, Gökçe Ö (2016). "Tribenoside and lidocaine in the local treatment of hemorrhoids: an overview of clinical evidence". Eur Rev Med Pharmacol Sci. 20 (12): 2742–51. PMID 27383331.
^ Jaques R (1977). "The pharmacological activity of tribenoside". Pharmacology. 15 (5): 445–60. doi:10.1159/000136721. PMID 578928.
^ Kikkawa Y, Takaki S, Matsuda Y, Okabe K, Taniguchi M, Oomachi K, Samejima T, Katagiri F, Hozumi K, Nomizu M (2010). "The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells". Biol Pharm Bull. 33 (2): 307–10. doi:10.1248/bpb.33.307. PMID 20118558.{{cite journal}}: CS1 maint: multiple names: authors list (link)
^ Hashizume H, Takigawa M (2005). "Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells". Acta Derm. Venereol. 85 (1): 47–50. doi:10.1080/00015550410024094. PMID 15848991.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

Zdroj:https://en.wikipedia.org?pojem=Tribenoside
Text je dostupný za podmienok Creative Commons Attribution/Share-Alike License 3.0 Unported; prípadne za ďalších podmienok. Podrobnejšie informácie nájdete na stránke Podmienky použitia.

[pmid27383331-1] Lorenc Z, Gökçe Ö (2016). "Tribenoside and lidocaine in the local treatment of hemorrhoids: an overview of clinical evidence". Eur Rev Med Pharmacol Sci. 20 (12): 2742–51. PMID 27383331.

[pmid578928-2] Jaques R (1977). "The pharmacological activity of tribenoside". Pharmacology. 15 (5): 445–60. doi:10.1159/000136721. PMID 578928.

[pmid20118558-3] Kikkawa Y, Takaki S, Matsuda Y, Okabe K, Taniguchi M, Oomachi K, Samejima T, Katagiri F, Hozumi K, Nomizu M (2010). "The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells". Biol Pharm Bull. 33 (2): 307–10. doi:10.1248/bpb.33.307. PMID 20118558.{{cite journal}}: CS1 maint: multiple names: authors list (link)

[pmid15848991-4] Hashizume H, Takigawa M (2005). "Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells". Acta Derm. Venereol. 85 (1): 47–50. doi:10.1080/00015550410024094. PMID 15848991.

[1]

[2]

[3]

[4]